Related references
Note: Only part of the references are listed.Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1
Meng Lv et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Monosomal karyotype is associated with poor outcomes in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia receiving chemotherapy but not allogeneic hematopoietic stem cell transplantation
Zongru Li et al.
ANNALS OF HEMATOLOGY (2020)
Very late relapse cases of TCF3-ZNF384-positive acute lymphoblastic leukemia
Akira Nishimura et al.
PEDIATRIC BLOOD & CANCER (2019)
The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia
Ya-Zhen Qin et al.
ANNALS OF HEMATOLOGY (2019)
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
Marketa Zaliova et al.
HAEMATOLOGICA (2019)
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression
Barbara J. McClure et al.
BRITISH JOURNAL OF CANCER (2018)
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology
Lanping Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
Yu Wang et al.
CANCER LETTERS (2018)
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
Jian-Feng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Genomic and Clinical Characterization of Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia
Takahiko Yasuda et al.
BLOOD (2018)
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP
Maoxiang Qian et al.
GENOME RESEARCH (2017)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi et al.
HAEMATOLOGICA (2017)
EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells
Akinori Yaguchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Genetic Basis of Acute Lymphoblastic Leukemia
Ilaria Iacobucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemia
ShenMiao Yang et al.
ONCOTARGET (2017)
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia
Marina Lafage-Pochitaloff et al.
BLOOD (2017)
Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults
Takahiko Yasuda et al.
NATURE GENETICS (2016)
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
Jinghui Zhang et al.
NATURE GENETICS (2016)
Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion
Mary Shago et al.
PEDIATRIC BLOOD & CANCER (2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu et al.
NATURE COMMUNICATIONS (2016)
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia
Yuan-Fang Liu et al.
EBIOMEDICINE (2016)
A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia
Y. Gocho et al.
LEUKEMIA (2015)
Treatment of High-Risk Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial
Josep-Maria Ribera et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia
Aurelie Caye et al.
HAEMATOLOGICA (2013)
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
Monique L. Den Boer et al.
LANCET ONCOLOGY (2009)
E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia
C-H Zhong et al.
LEUKEMIA (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)